Upload Avatar (500 x 500)
Jing Xin
xinjing@mail.xjtu.edu.cn
Chinese, English
Shaanxi
Xi'an Jiaotong University
Life Sciences
  • PhD: Xi'an Jiaotong University
  • Hosted several national and provincial research grants
  • Published multiple SCI papers
  • 2015.1-2018.7 - Xi'an Jiaotong University - Postdoctoral Researcher
  • 2018.7-2022.7 - Xi'an Jiaotong University - Assistant Professor
  • 2019.9-2020.9 - Dartmouth College, Thayer School of Engineering - Visiting Scholar
  • 2022.7-present - Xi'an Jiaotong University - Associate Professor
Intelligent precision optical diagnosis and treatment methods
Intelligent optical diagnostic and therapeutic quantitative assessment methods
  • Influence of Parameters on the Death Pathway of Gastric Cells Induced by Gold Nanosphere Mediated Phototherapy, Jing Xin, Lei Fu, Jing Wang, Sijia Wang, Luwei Zhang, Zhenxi Zhang, Cuiping Yao, 2022
  • A Nucleus-Targeted Nanosystem Integrated with Photodynamic Therapy and Chemotherapy, Jing Xin, Sijia Wang, Jing Wang, Lei Fu, Zhenxi Zhang, Cuiping Yao, 2022
  • Nanoliposomes co-encapsulating Ce6 and SB3CT against the proliferation and metastasis of melanoma with the integration of photodynamic therapy and NKG2D-related immunotherapy on A375 cells, Liu Huifang; Yao Cuiping; Zhang Luwei; Xin Jing; Zhang Zhenxi; Wang Sijia, 2021
  • Chlorin-Based Photoactivable Galectin-3-Inhibitor Nanoliposome for Enhanced Photodynamic Therapy and NK Cell-Related Immunity in Melanoma, Wang Sijia; Liu Huifan; Xin Jing; Rahmanzadeh Ramtin; Wang Jing; Yao Cuiping; Zhang Zhenxi, 2019
  • AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic®F127 nanomicellar drug carriers, Xin Jing; Wang Sijia; Wang Bing; Wang Jiazhuang; Wang Jing; Zhang Luwei; Xin Bo; Shen Lijian; Zhang Zhenxi; Yao Cuiping, 2018
  • Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low dose chemotherapeutic agents on gastric cancer cells., Xin Jing; Wang Sijia; Wang Jing; Wang Jiazhuang; Fu Lei; Zhang Luwei; Shen, Lijian Zhang, Zhenxi; Yao Cuiping, 2018
  • Nanosystem Integrated with Photosensitizer and Novel Targeting Chemotherapy Agent for Gastric Cancer Chemo-Photodynamic Combined Therapy, Xin Jing; Wang Sijia; Wang Jing; Wang Jiazhuang; Fu Lei; Zhang Luwei; Shen, Lijian Zhang, Zhenxi; Yao Cuiping, 2018
  • Cantharidin-encapsulated thermal-sensitive liposomes coated with gold nanoparticles for enhanced photothermal therapy on A431 cells, Sijia Wang, Jing Xin, Luwei Zhang, Yicheng Zhou, Cuiping Yao, Bing Wang, Jing Wang, Zhenxi Zhang, 2018
  • Activating of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis, Zhang L, Xia L, Zhao L, Chen Z, Shang X, Xin J, Liu M, Guo X, Wu K, Pan Y, Fan D, 2015
  • Decreased expression of FOXJ1 is a potential prognostic predictor for progression and poor survival of gastric cancer, Wang J, Cai X, Xia L, Zhou J, Xin J, Liu M, Shang X, Liu J, Li X, Chen Z, Nie Y, Fan D, 2015
  • Sensitized TiO2 nanocomposities through HMME linkage for photodynamic effects, He YL, Wang S, Zhang L, Xin J, Yao C, Zhang Z, Yang CC, 2016
  • Gold Nanoparticle Mediated Phototherapy for Cancer, Yao C, Zhang L, Wang J, He Y, Xin J, Wang S, Xu H, and Zhenxi Zhang, 2016
  • In vivo gastric cancer targeting and imaging using novel symmetric cyanine dye-conjugated GX1 peptide probes, Xin J, Zhang X, Liang J, Xia L, Yin J, Nie Y, Wu K, Tian J, 2013
  • ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells in vitro and its real-time evaluation by bioluminescence imaging in vivo, Xin J, Zhan Y, Xia L, Zhu H, Nie Y, Liang J, and Tian J, 2013
  • ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells, Xin J, Zhan Y, Xia L, Zhu H, Nie Y, Liang J, and Tian J, 2013
Optical Imaging Phototherapy Cancer Treatment Early Diagnosis Ai Algorithms Minimally Invasive Treatment Molecular Imaging Precision Medicine Quantitative Assessment Therapeutic Mechanisms

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.